£111.97

Woodhead Publishing Personalized Cancer Chemotherapy: An Effective Way of Enhancing Outcomes in Clinics

Price data checked 6 days ago

View at Amazon

Price History & Forecast

Last 85 days • 85 data points (No recent data available)

Historical
Generating forecast...
£112.39 £111.84 £111.96 £112.08 £112.20 £112.32 £112.44 25 January 2026 15 February 2026 08 March 2026 29 March 2026 19 April 2026

Price Distribution

Price distribution over 85 days • 1 price levels

Days at Price
85 days 0 21 43 64 85 £112 Days at Price

Price Analysis

Most common price: £112 (85 days, 100.0%)

Price range: £112 - £112

Price levels: 1 different prices over 85 days

Description

Product Description Personalized Cancer Chemotherapy separately describes and addresses "individualized cancer chemotherapy" (ICC) strategies new and old, to provide readers with new insights into their characteristics and techniques, as well as key debates and future trends in this area. The book devotes chapters to drug sensitivity testing, cancer biomarkers and bioinformatics detection, pharmacogenetics, individualized antimetastatic therapy, drug combinations, assistant chemotherapy, and cost-effectiveness considerations. A major obstacle to controlling cancer growth and metastases in patients is the inappropriate use of anticancer and antimetastatic drugs. Researchers and clinicians are now beginning to focus on ICC also called "personalized cancer chemotherapy" (PCC), to improve therapeutic quality and outcomes by selecting and prescribing the most appropriate and effective drugs. Using genetic, molecular, and bioinformatics data and modern experimental techniques, known tumor genes can be detected more easily than ever before; the average speed of genetic sequencing has increased 15,000 to 50,000 times since the Human Geonme Project was completed. This book will help readers understand the pros and cons of each individualized cancer chemotherapy strategy from different angles so as to make good judgments and predictions of drug responses and clinical outcomes. Explores the central components of cancer treatment Investigates new developments in cancer treatment Discusses the many strategies of individualized cancer chemotherapy Review This book explores the core essentials of cancer treatment and includes new insights into treatments About the Author Dr Da Yong Lu is an associate professor at Shanghai University, PR China studying cancer pathology, biochemistry, pharmacology and clinical therapeutics, especially on the pharmacological studies of new Chinese anticancer agent probimane and MST-16 and antimetastatic targets of fibrinogen and sialic acids and individualized cancer chemotherapy (ICC) and some articles in avian flu, AIDS and neural science. His research interests are focused on the basic studies of cancer biology, pathology, treatment, origins of life and other field of science disciplines. He is as an editorial member of several reputed international journals and has also published more than 50 scientific articles in international journals.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Pharmaceutical Perspectives of Cancer Therapeutics
95% match

Pharmaceutical Perspectives of Cancer Therapeutics

Springer

£139.95 11 Jan 2026
Cancer Chemotherapy: Basic Science to the Clinic
94% match

Cancer Chemotherapy: Basic Science to the Clinic

Wiley-Blackwell

£47.19 16 Feb 2026
Chemistry and Pharmacology of Anticancer Drugs
94% match

Chemistry and Pharmacology of Anticancer Drugs

CRC Press

£192.76 17 Apr 2026
CRC Press - Chemistry and Pharmacology of Anticancer Drugs
94% match

CRC Press - Chemistry and Pharmacology of Anticancer Drugs

CRC Press

£133.99 15 Apr 2026
Clinical Oncoproteomics: Proteome-Based Personalized Anti-Cancer Therapy
94% match

Clinical Oncoproteomics: Proteome-Based Personalized Anti-Cancer Therapy

£152.87 10 Mar 2026
Advances In Precision Medicine: Insights From Oncology Research And Clinical Applications
94% match

Advances In Precision Medicine: Insights From Oncology Research And Clinical Applications

£148.14 11 Feb 2026
Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)
94% match

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Humana

£147.91 10 Mar 2026
Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)
94% match

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Humana

£117.40 15 Jan 2026
Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)
94% match

Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)

Humana

£72.83 08 Mar 2026
Stem Cell Therapeutics for Cancer
94% match

Stem Cell Therapeutics for Cancer

Wiley

£98.00 08 Mar 2026
Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)
94% match

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)

Humana

£18.99 22 Jan 2026
Targeted Therapies in Oncology
94% match

Targeted Therapies in Oncology

CRC Press

£105.94 25 Feb 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
93% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£108.91 20 Apr 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
93% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£113.48 18 Apr 2026
Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted Therapy
93% match

Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted Therapy

Springer

£54.12 08 Mar 2026
Springer - Pharmacogenetics: Making Cancer Treatment Safer
93% match

Springer - Pharmacogenetics: Making Cancer Treatment Safer

Springer

£110.10 03 Mar 2026
Humana Combination Cancer Therapy: Modulators and Potentiators
93% match

Humana Combination Cancer Therapy: Modulators and Potentiators

Humana

£34.76 18 Apr 2026
Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)
93% match

Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)

Humana

£104.04 19 Apr 2026
Stem Cells and Cancer (Cancer Drug Discovery and Development)
93% match

Stem Cells and Cancer (Cancer Drug Discovery and Development)

Humana

£149.20 27 Jan 2026
Cancer Genetics and Genomics for Personalized Medicine
93% match

Cancer Genetics and Genomics for Personalized Medicine

Taylor & Francis

£96.49 12 Dec 2025
Cancer Vaccines as Immunotherapy of Cancer
93% match

Cancer Vaccines as Immunotherapy of Cancer

Academic Press

£101.29 08 Mar 2026
Personalized Medicine (Beyond Pet Biomarkers) (Biotechnology in Agriculture, Industry and Medicine)
93% match

Personalized Medicine (Beyond Pet Biomarkers) (Biotechnology in Agriculture, Industry and Medicine)

£122.68 03 Feb 2026
Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)
93% match

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Humana

£80.09 28 Feb 2026
Targeted Therapies in Oncology
93% match

Targeted Therapies in Oncology

CRC Press

£56.99 20 Feb 2026